TY - JOUR T1 - Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: Protocol for an observational cohort study (LongCOVID-study) JF - medRxiv DO - 10.1101/2022.01.10.22269009 SP - 2022.01.10.22269009 AU - Elizabeth N. Mutubuki AU - Tessa van der Maaden AU - Ka Yin Leung AU - Albert Wong AU - Anna D. Tulen AU - Siméon de Bruijn AU - Lotte Haverman AU - Hans Knoop AU - Eelco Franz AU - Albert Jan van Hoek AU - Cees C. van den Wijngaard Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/01/11/2022.01.10.22269009.abstract N2 - Background A substantial proportion of individuals infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) report persisting symptoms weeks and months following acute infection. Estimates on prevalence vary due to differences in study designs, populations, heterogeneity of symptoms and the way symptoms are measured. Common symptoms include fatigue, cognitive impairment and dyspnea. However, knowledge regarding the nature and risk factors for developing persisting symptoms is still limited. Hence in this study we aim to determine the prevalence, severity, risk factors and impact on quality of life of persisting symptoms in the first year following acute SARS-CoV-2 infection.Methods The LongCOVID-study is both a prospective and retrospective cohort study with a one year follow up. Participants aged 5 years and above with self-reported positive or negative tests for SARS-CoV-2 will be included in the study. The primary outcome is the prevalence and severity of persistent symptoms in participants that tested positive for SARS-CoV-2 compared to controls. Symptom severity will be assessed for fatigue using the Checklist Individual Strength (CIS subscale fatigue severity), pain (Rand-36/SF-36 subscale bodily pain), dyspnea (Medical Research Council (mMRC)) and cognitive impairment using the Cognitive Failure Questionnaire (CFQ). Secondary outcomes include loss of health-related quality of life (HRQoL) and risk factors for persisting symptoms following infection with SARS-CoV-2.Discussion A better understanding regarding the nature of persisting symptoms following SARS-CoV-2 infection will enable better diagnosis, management and will consequently minimize negative consequences on quality of life.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study is funded by Dutch Ministry of Health, Welfare and Sport. The funders do not have a role in the design of this study, its execution, analyses, interpretation of results, approval of the manuscript and decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Utrecht Medical Ethics Committee (METC) declared in February 2021 that the Medical Research Involving Human Subjects Act (WMO) does not apply to this study (METC protocol number 21-124/C).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis article is a protocol for an observational cohort study, hence data sharing is not applicable as no datasets were generated or analyzed during the current study.SARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus-2CISChecklist Individual StrengthmMRCMedical Research CouncilHRQoLHealth-Related Quality of LifeRIVMDutch National Institute for Public Health and the EnvironmentMETCMedical Ethics Review CommitteeWMOMedical Research Involving Human Subjects ActPCRPolymerase Chain ReactionBRPBasic Registration of PersonsGGDMunicipal Health ServicesCFQCognitive Failure QuestionnaireBrief IPQThe Brief Illness Perception QuestionnaireHADSHospital Anxiety and Depression ScaleNCSINijmegen Clinical Screening InstrumentiPCQiMTA Productivity Cost QuestionnairePedsQLPediatric Quality of Life InventoryPedsQL fatiguePediatric Quality of Life Inventory Fatigue ScaleVASVisual Analogue ScalePROMISPatient-Reported Outcomes Measurement Information SystemQALYsQuality Adjusted Life YearsSDQStrengths and Difficulties Questionnaire ER -